Medical information Clinical review pending

Genetic Testing

NF2 Gene Neurofibromatosis Type 2 Genetic Test

The NF2 Gene Neurofibromatosis Type 2 Genetic Test identifies mutations in the NF2 gene associated with Neurofibromatosis Type 2 (NF2), a condition causing nervous system tumors. This test aids in diagnosis and management, especially for those with a family history.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question

Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample: Blood sample (EDTA tube), extracted DNA, or one drop of blood on an FTA card.
Results: Confirm with the laboratory before booking.
Preparation: No specific fasting is required. Please inform the laboratory if you are taking any medications. A clinical history and genetic counseling session, including pedigree chart creation, is essential before testing.

Test priceKSh 40,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the NF2 Gene Neurofibromatosis Type 2 Genetic Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

Insurer or scheme name & policy / member number
A clinician's request / prescription for the test
Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

Full name *

Mobile number *

+254

Insurer or scheme

Policy / member number (optional)

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

WhatsApp the claims team Call us

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

✓Individuals with a personal or family history of Neurofibromatosis Type 2 (NF2).
✓Patients presenting with symptoms suggestive of NF2, such as hearing loss, tinnitus, balance problems, or skin tumors.
✓Confirmation of NF2 diagnosis.
✓Genetic counseling for individuals with NF2 or a family history of NF2.
✓Prenatal or preimplantation genetic diagnosis (requires consultation).

In plain language

What this test helps you understand

This test helps identify individuals with mutations in the NF2 gene, confirming a diagnosis of Neurofibromatosis Type 2 (NF2). It can aid in understanding the genetic basis of the condition, guiding clinical management, and informing family members about potential risks.

The NF2 Gene Neurofibromatosis Type 2 Genetic Test is a diagnostic tool used to identify mutations in the NF2 gene. These mutations are linked to Neurofibromatosis Type 2 (NF2), a genetic disorder characterized by the growth of non-cancerous tumors in the nervous system, often affecting hearing and balance nerves. Understanding your genetic status can be important for managing the condition and understanding potential risks for family members. This test uses Next-Generation Sequencing (NGS) technology to analyze DNA for specific changes in the NF2 gene. Results can help confirm a diagnosis, guide treatment decisions, and inform family planning. A genetic counseling session is recommended to discuss the test and interpret the results.

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

Speak with us

We check the test and answer your questions before collection.

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

Understand your report

A counselor helps you understand the result and the next steps.

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →

PreparationNo specific fasting is required. Please inform the laboratory if you are taking any medications. A clinical history and genetic counseling session, including pedigree chart creation, is essential before testing.

SampleBlood sample (EDTA tube), extracted DNA, or one drop of blood on an FTA card.

MethodologyNext-Generation Sequencing (NGS) of the NF2 gene.

PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.

This test primarily detects mutations within the NF2 gene. It may not detect all possible mutations, such as large deletions or duplications, depending on the specific methodology used. Results should be interpreted in conjunction with clinical findings and family history. This test does not assess the risk of developing other conditions.

Read your report

What common result terms mean

TermPlain-language meaning

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.

NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.

VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.

Questions people ask

Frequently asked questions

NF2 is a genetic disorder that causes tumors to form on nerve tissue. These tumors typically develop on the nerves responsible for hearing and balance, but can also affect other nerves in the brain, spinal cord, and peripheral nervous system.

Testing may be recommended for individuals with symptoms suggestive of NF2, those with a family history of the condition, or for genetic counseling purposes.

The test involves analyzing a sample of your DNA (usually from a blood sample) to look for specific changes (mutations) in the NF2 gene.

Results will indicate whether mutations in the NF2 gene were detected. A genetic counselor or physician will help interpret the results in the context of your personal and family medical history.

Yes, a genetic counseling session is essential before testing to discuss the implications, benefits, and limitations of the test, and after testing to help understand the results.

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

ACMG/AMP technical standards for sequence variant interpretation
ClinGen curation and gene–disease validity frameworks where applicable
LOINC-coded reporting for interoperable results
ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

Last updated: September 27, 2026
Medical review: not yet completed
Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →

Chat on WhatsApp